Features

trans-Δ9-tetrahydrocannabinol

Selective Inhibition Shows Promise as Marijuana Treatment
Diana Martinez, MD and Pierre Trifilieff, PhD

A promising treatment option for addiction to marijuana may emerge through selective inhibition of a specific signaling pathway in the brain.





Medicaid Coverage Map

State Medicaid Coverage of Addiction Treatment in the US
Beth Haynes

To help further knowledge of current care coverage, ASAM has produced two-page state fact sheets that summarize Medicaid coverage of both medication and counseling addiction treatment.

Breaking News

  • 9/26/2014

    DEA Reschedules Hydrocodone Combination Products

    On August 22nd, the US Drug Enforcement Agency (DEA) formally rescheduled hydrocodone combination products (HCPs), moving them from Schedule III to Schedule II of the Controlled Substances Act.

Education & Training

Government Affairs

  • 09/26/2014

    DEA Reschedules Hydrocodone Combination Products

    On August 22nd, the US Drug Enforcement Agency (DEA) formally rescheduled hydrocodone combination products (HCPs), moving them from Schedule III to Schedule II of the Controlled Substances Act.

Your ASAM

  • 08/13/2014

    Speaking for Addiction in the AMA

    ASAM Member Dr. Todd Kammerzelt writes about his experience serving on the American Medical Association's Young Physician Section and the opportunity to educate colleagues about addiction

OP-ED

  • 07/07/2014

    Editorial: Tobacco Still Leading Preventable Cause of Death

    According to the latest surgeon general's report, smoking has killed more than 20 million people since the first report was issued. Two and a half million of those people were nonsmokers who died from breathing secondhand smoke.